TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research January 30, 1998
TCL Archive Meta-Analysis Of Randomized Trials Shows Aspirin Reduces Colon Polyp Recurrence February 27, 2009
